Skip to main content
. 2022 Dec 26;62(1):101–112. doi: 10.1007/s40262-022-01191-6

Fig. 1.

Fig. 1

Oberved dose-normalized upadacitinib concentrations from ulcerative colitis (UC) patients during the induction and maintenance periods and compared to other patient populations [rheumatoid arthritis (RA), atopic dermatitis (AD), and psoriatic arthritis (PsA)]. Open circles represent individual observations. Circles and error bars represent median and 5th to 95th percentiels of observations within each time bin